Edition:
Deutschland

AbbVie Inc (ABBV.N)

ABBV.N on New York Stock Exchange

105.60USD
23 May 2018
Change (% chg)

$-0.63 (-0.59%)
Prev Close
$106.23
Open
$105.85
Day's High
$106.25
Day's Low
$104.74
Volume
2,061,596
Avg. Vol
1,735,532
52-wk High
$125.84
52-wk Low
$65.43

ABBV.N

Chart for ABBV.N

About

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology,... (more)

Buy/Sell

Sell Hold Buy
2.35 Mean rating from 23 analysts

Overall

Beta: 1.53
Market Cap(Mil.): $144,249.59
Shares Outstanding(Mil.): 1,594.09
Dividend: 0.64
Yield (%): 2.83

BRIEF-AbbVie Inc Says On May 17, Entered Loan Credit Agreement To Borrow Up To $3 Bln

* ABBVIE INC - ON MAY 17, ENTERED TERM LOAN CREDIT AGREEMENT TO BORROW TERM LOANS ON AN UNSECURED BASIS OF UP TO $3 BILLION - SEC FILING Source http://bit.ly/2IuwcL8 Further company coverage:

UPDATE 2-Roche wins reprieve as Novartis biosimilar delayed in U.S.

LONDON/ZURICH, May 3 Roche has won a reprieve from an expected wave of cheaper versions of its biotech cancer drugs as U.S. regulators knocked back a biosimilar form of rituximab from Swiss rival Novartis.

REFILE-Goldman's Waldron says U.S. tax reform boosts shareholder activism

LOS ANGELES, May 2 U.S. companies with more cash on their balance sheets thanks to tax reform are coming under greater scrutiny from activist investors, a top Goldman Sachs Group Inc investment banker said this week.

RPT-Apple plows U.S. tax cuts into record share buybacks

SAN FRANCISCO, May 2 Apple Inc lavished cash on its shareholders like no company in history in the first three months of the year and it intends to keep doing so, making the iPhone maker's investors the clearest winners yet from last year's sweeping U.S. corporate tax cuts.

Apple plows U.S. tax cuts into record share buybacks

SAN FRANCISCO, May 1 Apple Inc lavished cash on its shareholders like no company in history in the first three months of the year and it intends to keep doing so, making the iPhone maker's investors the clearest winners yet from last year's sweeping U.S. corporate tax cuts.

BRIEF-Abbvie Estimates Complete Blackout Could Begin As Soon As 4 P.M NY Time on May 23

* ABBVIE - ESTIMATE THAT COMPLETE BLACKOUT COULD BEGIN AS SOON AS 4 P.M., NEW YORK CITY TIME ON MAY 23, 2018 AND COULD EXTEND THROUGH JUNE 13, 2018 Further company coverage:

Gilead hepatitis C drug sales slump, shares fall 5 percent

Gilead Sciences Inc reported a lower quarterly profit on Tuesday as sales of its flagship hepatitis C drugs fell by a greater-than-expected 59 percent, sending shares of the biotechnology company down 5 percent.

UPDATE 1-Gilead hepatitis C drug sales slump, shares fall 5 pct

May 1 Gilead Sciences Inc reported a lower quarterly profit on Tuesday as sales of its flagship hepatitis C drugs fell by a greater-than-expected 59 percent, sending shares of the biotechnology company down 5 percent.

UPDATE 4-Pfizer 1st-qtr results miss estimates as key drug sales fall short

NEW YORK, May 1 Pfizer Inc on Tuesday reported lower-than-expected first-quarter revenue as demand for some key drugs and international sales fell short of estimates, sparking a 5.1 percent drop in shares of the largest U.S. drugmaker.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -1.01%
Rohstoffe -0.41%
Industrie -0.14%
Konjunktur abhängige Waren & Dienstleistungen +0.32%
Konjunktur unabhängige Waren & Dienstleistungen -0.57%
Finanzindustrie +0.11%
Pharma +0.74%
Technologie -0.31%
Telekommunikation +0.41%